Share
News
-
15 November 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 18 October 2012
In this issue of Danish Pharmacovigilance Update, read about: Risk of developing hepatotoxicity in patients undergoing treatment with agomelatine (Valdoxan®)
-
17 October 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 20 September 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: New definition of adverse reactions due to new European legislation on pharmacovigilance.
-
10 October 2012 /News - miscellaneous
Contaminated medication possibly linked to several meningitis outbreaks in the USA
The health authorities in the USA are presently investigating the cause of a large number of meningitis outbreaks caused by the fungus Aspergillus. In the USA, only those who received the medication in question have been infected, and there have been no reports of transmission from persons to person.
-
05 October 2012 /News - miscellaneous
Warning against illegal potency enhancers
The Danish Health and Medicines Authority warns against widespread sale of illegal potency enhancers. Over the first nine months of 2012, the Danish Health and Medicines Authority was made aware of 54 illegal potency-enhancing products found to contain active pharmaceutical ingredients not declared anywhere on the package or in the product information. The findings are a result of international cooperation.
-
04 October 2012 /News - miscellaneous
INTERPOL-coordinated operation against illegal internet sale of medicines
Last week, the Danish Health and Medicines Authority took place in a global operation code-named PANGEA V against illegal online trading of medicines together with the Danish tax and customs authorities (SKAT), the Danish Police and the Danish Veterinary and Food Administration. The operation was joined by more than 190 authorities from 100 countries all over the world.
-
06 September 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 16 August 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Maximum single dose of intravenous ondansetron (Zofran® and others) now restricted to 16 mg.
-
03 August 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 21 June 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Decrease in the number of intoxications and suicide attempts using drugs containing acetylsalicylic acid or paracetamol.
-
31 July 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 24 May 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Drug Analysis Prints involving data from more than 14,000 Danish adverse reaction reports available at the Danish Health and Medicines Authority’s website.
-
04 July 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 19 April 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Split and crushed tablets containing finasteride may pose a risk for pregnant and fertile women.
-
19 June 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 15 March 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: A new registry study has investigated the frequency of malformations in newborns after treating the mother with antidepressants (SSRI) during the pregnancy.
-
05 March 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 16 February 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Risk of overdose with methotrexate in the treatment of rheumatoid arthritis as well as intensified monitoring of heart rate and blood pressure in connection with treatment with Gilenya.
-
24 February 2012 /News - miscellaneous
Changed opening hours on 29 February and 1 March
In connection with the merger with the Danish National Board of Health, the Danish Medicines Agency will be closed on 29 February until 12:00 noon.On Thursday 1 March, the reception and main entrance at Axel Heides Gade will be closed until 11:30.
-
30 January 2012 /News - miscellaneous
No signs of correlation between urine-derived fertility products and Creutzfeldt-Jakob
Foreign reports have described detection of prion in urine-derived fertility hormones, and there have been speculations about a possible association with Creutzfeldt-Jakob Disease. A linkage of Danish registers has provided no basis for such a conclusion.
-
26 January 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 19 January 2012
In this issue of Danish Pharmacovigilance Update read about the risk that patients treated with statins develop diabetes, and proton-pump inhibitors (PPI) and the risk of hypomagnesaemia with long-term use.
-
09 January 2012 /News - miscellaneous
Still possible to report suspected illegal activities with medicines anonymously
At the end of 2010, the Danish Medicines Agency made it possible for people to file an anonymous report on suspected illegal activities with medicines. During 2012, the Danish Medicines Agency will expand the scheme, making it possible to report anonymously any illegal activities in areas regulated by the Danish Medicines Agency in the form of medical devices, tissues and cells, etc.
-
03 January 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 15 December 2011
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Atomoxetine (Strattera®) and the risk of increased blood pressure and heart rate, increased suspicion of risk of congenital malformations with the antiepileptic topiramate (Topimax® and others), and new recommendations for the antidepressant escitalopram.
